Capgemini-建设下一代制药实验室-数字化连接，环境可持续（英）-2024-68页_13mb

Summary Analysis: Capgemini Report on Next-Gen Pharma Labs

This report from Capgemini Research Institute examines the transformation of pharmaceutical laboratories to meet industry demands for innovation, efficiency, and sustainability. Key findings highlight that next-gen labs, characterized by digitalization, AI, automation, and sustainability, are becoming essential for accelerating drug discovery, reducing costs, and improving approval rates.

Current State of Lab Transformation:

• Most organizations (around 90%) face barriers such as legacy technologies, data silos, skills shortages, and regulatory compliance challenges.
• Investment in lab transformation is expected to rise, with large organizations planning to invest 6.5% of revenue by 2025, up from 4% in 2022.
• Only 15% of surveyed labs are mature "leaders," with most at early stages like pilots or proof-of-concept (PoC).

Drivers and Benefits:

• Primary drivers include reducing time to market, cutting costs, and enhancing success rates for drug discovery.
• Leaders (15% of organizations) achieve significant benefits, such as a 50% reduction in time to market and human errors, and 43% reduction in late-stage failures and costs.
• Genomics and data growth fuel challenges, with solutions like FAIR data principles and advanced AI applications.

Recommendations for Building a Next-Gen Lab:

• Start with a clear strategy and roadmap aligned with organizational goals.
• Design a future-ready architecture, focusing on cloud integration, cybersecurity, and interoperable tools.
• Build intelligence through AI and FAIR data practices to enable global collaboration and efficiency.
• Optimize processes with automation, robotics, and harmonized workflows.
• Foster collaboration with external partners and internal teams, leveraging the "lab-as-a-service" model.
• Strengthen sustainability by adopting green chemistry and embedding it into lab operations.
• Develop data-driven, future-ready skills to address talent gaps in digital and domain expertise.

Future Outlook:

• Next-gen labs will be seamlessly integrated, digitally connected, and environmentally sustainable, leveraging technologies like AI, generative AI, and synthetic biology.
• The transformation journey requires a holistic approach, continuous monitoring, and scalability to unlock full potential.

Overall, this report provides actionable insights for pharma organizations to navigate lab transformation, supported by survey data and case studies from industry leaders.